BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:GT737 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of GT737\, from ClinicalTrials.gov estimates
 .
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07676006-2964@assetmemo.bio
DTSTAMP:20261121T005442Z
DTSTART;VALUE=DATE:20300630
DTEND;VALUE=DATE:20300701
SUMMARY:GT737: Phase 1 readout est. (NCT07676006)
DESCRIPTION:GT737\, phase 1\, Acute Myeloid Leukemia.\nStudy: A Clinical St
 udy to Investigate the Safety and Efficacy of Off-the-Shelf iNKT Cell Inje
 ction Targeting CD33/CD70 in Adult Patients With Relapsed/Refractory Acute
  Myeloid Leukemia\nEstimated primary completion: June 2030. This is a Clin
 icalTrials.gov estimate\, not a confirmed readout date\, and it can move.\
 nDrug page: https://assetmemo.bio/drug/gt737#upcoming-events\nRegistry rec
 ord: https://clinicaltrials.gov/study/NCT07676006
URL:https://assetmemo.bio/drug/gt737#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
